Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in
Home>Events>This Event
  Events - May 2014

PharmAccess Leaders Forum

19 May 2014 - 21 May 2014 - Paris, France

Bookmark and Share

NextLevel Pharma’s PharmAccess Leaders Forum is quickly becoming THE “must attend” event for senior representatives of the market access community in Europe. With over 30 senior-level speakers from Payers, HTAs, Hospitals, stakeholder groups, and not to mention the pharmaceutical industry, more than 100 participants will attend. Attendees will achieve the most relevant learning, benchmarking and networking experience available for senior executives who are involved in patient access, health economics, outcomes, pricing and reimbursement. 3 EVENTS IN ONE: 1. Innovative Pricing & Reimbursement Agreements 2. Achieving Market Access for High-Value Oncology Therapeutics 3. Best Practices in Economic Modeling to Demonstrate Superior Outcomes & Value This year’s “Spring Edition” in Paris, will focus the audience on the necessary steps to achieving rapid market access, through enhanced value-demonstration, whilst delivering as much certainty as possible for payers, as well as delivering the patient with the most innovative & beneficial products possible. Request agenda at or contact me directly for more information. We look forward to meeting you in Paris!

Further information
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
World’s First Therapeutic Venom Database
Open-source library describes nearly 43,000 effects on the human body.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Metabolic Profiles Distinguish Early Stage Ovarian Cancer with Unprecedented Accuracy
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
The Do’s and Don’ts of SPR Experiments
Surface Plasmon Resonance (SPR) is a technique that is becoming more widely used, particularly by anyone who wants to obtain accurate on (association) and off (dissociation) rates for biomolecular binding.
Long-Sought Protein Sensor for the ‘Sixth Sense’ Discovered
In a study led by scientists from The Scripps Research Institute (TSRI)the sensor protein for propioception has been identified.
New Anti-Malarial Drug Screening Model
University of South Florida researchers demonstrate novel chemogenomic profiling to identify drug targets for the most lethal strain of malaria.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
Scroll Up
Scroll Down

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos